摘要
药物性肾损伤在新药开发过程和临床用药中十分常见, 许多药物可引起不同程度的肾脏损伤, 包括肾小管间质性、肾小球性和肾血管性疾病。深入研究药物性肾损害产生的分子机制, 对降低新药开发风险、临床合理用药、早期发现不良反应和采取有效防治措施均有着重要意义。
Drug-induced nephrotoxicity is very common in both new drug development and clinic practice. Various drugs can induce kidney injuries, including tubulointerstitial, glomerular and renal vascular disease. To investigate the mechanism of drug induced nephrotoxicity is important for risk reduction of new drug development, reasonable drug usage, early discovery and effective prevention/treatment of adverse effects in clinics.
出处
《药学学报》
CAS
CSCD
北大核心
2010年第10期1199-1204,共6页
Acta Pharmaceutica Sinica
基金
国家科技重大专项“重大新药创制”(2008ZX09305-007
2009ZX09501-033)
关键词
药物性肾损伤
急性肾小管坏死
小管间质性肾炎
drug induced kidney injury
acute tubular necrosis
tubulointerstitial nephritis